Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Pombier SamanthaVice President and Controller | Grant or award | A | — 14 sh | Sep 21, 2026 |
| 4 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $50K 2,920 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 4 | Anderson David HugoDirector | Open-market sale · 10b5-1 plan | SELL | $72K 1,500 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 3 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $80K 6,968 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 3 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $180K 5,840 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 3 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Kuzoyan VaheDirector, President | Derivative conversion | C | — 3,148 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Sousa Mauad BrunoDirector | Derivative conversion | C | $48K 1,619 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 2 | Hohl BenjaminCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | $59K 3,982 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion | C | — 3,148 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Flower JohannaDirector | Grant or award | A | — 56 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Option exercise · 10b5-1 plan | M | — 5,000 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $50K 2,920 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $180K 5,840 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $80K 6,968 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Akinsanya KarenSee Remarks | Option exercise · 10b5-1 plan | M | — 31.6K sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Hohl BenjaminCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | — 3,982 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 54 | Cardenuto Rodolpho CDirector | Open-market sale | SELL | $878K 5,321 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 54 | Adelborg AusteSecretary | Open-market sale | SELL | $613K 6,834 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 53 | Avella Christopher JohnChief Financial Officer | Open-market sale | SELL | $4.89M 56.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 52 | Mackey Cameron KeyserChief Operating Officer | Open-market sale | SELL | $11.13M 125.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 52 | Shen Ching Hang10% Owner | Open-market purchase | BUY | $5.00M 878.7K sh | Sep 18, 2026 traded Sep 15, 2026 |
| 35 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $3.77M 40.6K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 35 | Budur KumarCHIEF MEDICAL OFFICER | Open-market sale | SELL | $1.54M 35.9K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 34 | Konowiecki Joseph SDirector, EVP, Corporate Affairs | Open-market sale | SELL | $202K 23.5K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 33 | Cox John DDirector | Open-market purchase | BUY | $59K 12.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 32 | Schrenk Troy C.Chief Commercial Officer | Open-market purchase | BUY | $125K 5,907 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 32 | Allen William TDirector | Open-market sale | SELL | $241K 26.2K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 31 | Aviv David MelehChief Technology Officer | Open-market sale | SELL | $461K 15.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 31 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $3.04M 33.2K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 30 | Cislini JeffSVP & General Counsel | Open-market sale · 10b5-1 plan | SELL | $660K 3,314 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 29 | Graves Jeffrey ADirector, President and CEO | Open-market sale | SELL | $152K 42.7K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 29 | Nordstrom Phyllis BEVP, CFO and CAO | Open-market sale | SELL | $107K 30.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 29 | Saunders Scott JDirector | Open-market sale | SELL | $43K 203 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 29 | Kritzmire Anne W.Director | Open-market purchase | BUY | $6,234 300 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 28 | Tannenbaum Leonard MDirector, 10% Owner | Open-market purchase | BUY | $88K 25.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 28 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | Open-market sale | SELL | $301K 3,039 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 28 | MacKay Craig CDirector | Open-market sale | SELL | $109K 2,000 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 28 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | Open-market sale | SELL | $407K 4,141 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 27 | Rosen TamiDirector | Open-market sale · 10b5-1 plan | SELL | $173K 8,504 sh | Sep 18, 2026 traded Sep 18, 2026 |